BindingDB logo
myBDB logout

BDBM50238075 CHEMBL4103188

SMILES: CNC(=O)Cn1ncc2nccc(Nc3cc(ncc3C)-c3cc(C)ccc3F)c12

InChI Key: InChIKey=QCWDLALWOCJZPV-UHFFFAOYSA-N

Data: 1 IC50  2 EC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50238075   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
TGF-beta receptor type-1


(Homo sapiens (Human))
BDBM50238075
PNG
(CHEMBL4103188)
Show SMILES CNC(=O)Cn1ncc2nccc(Nc3cc(ncc3C)-c3cc(C)ccc3F)c12
Show InChI InChI=1S/C22H21FN6O/c1-13-4-5-16(23)15(8-13)19-9-18(14(2)10-26-19)28-17-6-7-25-20-11-27-29(22(17)20)12-21(30)24-3/h4-11H,12H2,1-3H3,(H,24,30)(H,25,26,28)
PDB
MMDB

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 16n/an/an/an/an/an/a



Takeda California

Curated by ChEMBL


Assay Description
Inhibition of recombinant N-terminal GST tagged human ALK5 (200 to 503 residues) expressed in baculovirus expression system using FAM-NH2-KVLTQMGSPSI...


Bioorg Med Chem Lett 27: 1955-1961 (2017)


Article DOI: 10.1016/j.bmcl.2017.03.026
BindingDB Entry DOI: 10.7270/Q2QJ7KKZ
More data for this
Ligand-Target Pair
TGF-beta receptor type-1


(Homo sapiens (Human))
BDBM50238075
PNG
(CHEMBL4103188)
Show SMILES CNC(=O)Cn1ncc2nccc(Nc3cc(ncc3C)-c3cc(C)ccc3F)c12
Show InChI InChI=1S/C22H21FN6O/c1-13-4-5-16(23)15(8-13)19-9-18(14(2)10-26-19)28-17-6-7-25-20-11-27-29(22(17)20)12-21(30)24-3/h4-11H,12H2,1-3H3,(H,24,30)(H,25,26,28)
PDB
MMDB

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 1.59E+3n/an/an/an/a



Takeda California

Curated by ChEMBL


Assay Description
Inhibition of ALK5 in human Calu6 cells assessed as reduction in Smad2/3 phosphorylation


Bioorg Med Chem Lett 27: 1955-1961 (2017)


Article DOI: 10.1016/j.bmcl.2017.03.026
BindingDB Entry DOI: 10.7270/Q2QJ7KKZ
More data for this
Ligand-Target Pair
TGF-beta receptor type-1


(Homo sapiens (Human))
BDBM50238075
PNG
(CHEMBL4103188)
Show SMILES CNC(=O)Cn1ncc2nccc(Nc3cc(ncc3C)-c3cc(C)ccc3F)c12
Show InChI InChI=1S/C22H21FN6O/c1-13-4-5-16(23)15(8-13)19-9-18(14(2)10-26-19)28-17-6-7-25-20-11-27-29(22(17)20)12-21(30)24-3/h4-11H,12H2,1-3H3,(H,24,30)(H,25,26,28)
PDB
MMDB

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/an/an/a 126n/an/an/an/a



Takeda California

Curated by ChEMBL


Assay Description
Inhibition of ALK5 (unknown origin) expressed in SBE-bla HEK293T cells assessed as decrease in TGFbeta1-induced Smad2/3 phosphorylation by beta lacta...


Bioorg Med Chem Lett 27: 1955-1961 (2017)


Article DOI: 10.1016/j.bmcl.2017.03.026
BindingDB Entry DOI: 10.7270/Q2QJ7KKZ
More data for this
Ligand-Target Pair